ABSTRACT Pulmonary fat embolism occurs frequently after trauma but its functional significance is often unclear. To obtain direct evidence of lung damage caused by fat embolism we have measured changes in permeability of the alveolar-capillary interface. A permeability index was derived from the half time clearance from lung to blood (T-LB) of 99mTc DTPA introduced into the lung in a 1 ml bolus. Three groups ofrabbits were studied. Baseline Tw LB. did not differ significantly between groups. After intravenous injection of saline placebo in one group and of 300 mg/kg triolein in another group there was no change in permeability index. After intravenous injection of 100 mg/kg oleic acid in the third group there was an immediate change in T' LB from a monoexponential baseline 280 ± 20 min (SEM) to a multiexponential curve which was resolved into two components, one with a T'LB of 3-2 ± 0-6 min (SEM) and the other 39 5 ± 7-6 min (SEM). Statistically significant changes in alveolar-arterial Po2 difference, dynamic compliance, chest radiography, and postmortem lung water accompanied the changes in T'LB in this group. There were no significant changes in these variables in the placebo or triolein group. Histological studies of the lung tissue of these animals using the osmic acid stain for fat showed no fat in the placebo group, extensive fat embolisation which was densely stained in the triolein group and much less densely stained fat in the oleic acid group. Measurement of the permeability of the alveolar-capillary interface provides direct evidence of lung damage after oleic acid embolisation. There were no functional changes in animals with extensive embolisation with triolein.
Fat emboli are frequently found in the lungs of trauma victims' 2 although few of these patients have respiratory symptoms.' However from 30-50 % of patients after trauma have an arterial oxygen tension reduced below 80 mmHg (11 kPa) while breathing air and this has been assumed, without direct evidence, to be caused by subclinical pulmonary fat embolism.' While it is possible that fat embolism may be the cause of a low Pao2 in some patients, the demonstration of hypoxia by itself gives only indirect evidence of lung injury since a fall in Pao2 may also be caused by hypoventilation, breathing at low lung volume, and in some subjects by assuming the supine or Trendelenberg position.
Even if fat can be demonstrated clinically in the lung3 this need not necessarily be causally related to functional impairment because of the different effects of different types of fat on the lung. 4 In the absence of a specific clinical test for fat in the lung or of its sequelae, in terms of lung dysfunction, we have examined the following hypothesis. Different types of fat embolus may induce measurable differences in the degree of damage to the alveolarcapillary interface and this damage may be measured using a simple radioactive tracer clearance technique.
In this study we have embolised the lung with either neutral fat or oleic acid. The neutral fat used was triolein and was chosen to resemble closely the composition of marrow fat. Oleic acid has been widely used as a model of fat embolism but its effects on pulmonary epithelial permeability have not been studied using the minimally invasive permeability method that we have described.
We have developed a method for measuring pulmonary epithelial damage using the clearance rate of 99mTc DTPA (diethylene triamine pentacetate) from lung to blood.5 After embolisation of the lungs of animals with either neutral fat or oleic acid we have compared the change in pulmonary epithelial permeability with other changes in lung structure and function. We have shown that the permeability index is a sensitive test of lung damage induced by oleic acid, whereas massive embolisation with neutral fat produced neither change in epithelial permeability nor change in lung function. Thus even if it were possible to demonstrate fat in the lung in vivo, a more important test from the point of view of lung function is the demonstration of damage at the alveolar-capillary interface.
Methods
New Zealand white rabbits were anaesthetised with an intramuscular injection of 1 ml of HypnormR (0-2 mg fentanyl base per ml and 10 mg of fluanisone per ml, Janssen Pharmaceutical), followed 30 min later by 01 ml Hypnorm intravenously into an ear vein. The animals were ventilated with 30% 02, 70 % N20 in the prone position, via a tracheostomy, using a Harvard small animal ventilator. A catheter was inserted into an ear artery. Tracheal air flow was measured with a heated Fleisch 0 pneumotachograph; the flow signal was integrated and displayed on a pen recorder, together with airway pressure (Paw) and arterial pressure. The inspired oxygen concentration was measured with a Servomex paramagnetic oxygen analyser and arterial blood gas tensions with an IL automatic blood gas analyser.
The following measurements were made before and after intravenous injections of either neutral fat, oleic acid, or saline placebo: pulmonary epithelial permeability; alveolar-arterial oxygen gradient; dynamic compliance; lung radiographic score.
Postmortem measurements were made of lung wet weight/bloodless dry weight ratio and in a separate group of animals the lungs were fixed in formalin and used to stain for the presence of fat.
PULMONARY EPITHELIAL PERMEABILITY
An index of pulmonary epithelial permeability was derived from the half time clearance rate of 99mTc DTPA (MW 492 Daltons) from lung into blood. This technique is similar to that previously described for use in man,5 6 although in animals the tracer is introduced into the lung in a small bolus.7 Two collimated miniature scintillation detectors were positioned, one over the lungs and one over the head. A 1 ml bolus of 99mTc DTPA in saline was injected into the lung via a fine catheter whose tip was located at the carina. This was followed by 0 5 ml of saline and 1 ml of air. The lung detector was moved until a Jones, Minty, Beeley, Royston, Crow, Grossman maximum reading was obtained and counts from the lung and head were obtained for 20 second epochs every minute for the duration of the study. The lung detector recorded activity from part of lung and vascular tissues in its field of view. The increase in tissue background radioactivity in the field of this detector was corrected, using the signal from the head detector in the following manner. Towards the end of the study period the animal was given an intravenous injection of 20 pLCi of 99mTc DTPA. This produced an increase in signal in both head and lung detector proportional to the radioactivity in the vascular tissues in the two detector fields. The ratio of the increase in count rate in the lung field to the increase in count rate in the head field was calculated. For each minute after tracheal instillation of the tracer, the head count rate was multiplied by this ratio and the product subtracted from the lung count rate. The resulting lung to blood clearance curve represented the rate of declining activity in the lung alone and the time for this corrected curve to fall to half the peak activity was used as an index of pulmonary epithelial permeability (Ti LB).
ALVEOLAR-ARTERIAL OXYGEN TENSION DIFFERENCE (A-aPo2)
The alveolar-arterial oxygen tension difference was calculated from the arterial blood gas tensions and the inspired oxygen concentration assuming a respiratory quotient of0-8. 
PROCEDURE
With the animals anaesthetised and mechanically ventilated baseline measurements were made of A-aPo2 difference, Cdyn, and chest radiographic score. Then 99mTc DTPA was instilled into the airway and the clearance curve was constructed. Measurements of A-aPo2 difference, Cdyn, and chest radiographic score were repeated 30 minutes after isotope instillation. At this time the A-aPo2 and Cdyn had returned to baseline and the animals were divided into three groups: group 1 (n = 8) was given oleic acid intravenously (100 mg/kg body wt); group 2 (n = 8) was given triolein intravenously (99% in sealed ampoules refrigerated under nitrogen, Sigma Ltd) (300 mg/kg body wt); and group 3 (n = 6) was given a comparable volume of saline intravenously. Repeated measurements of A-aPo2 difference, Cdyn, and chest radiograph were then made 15, 30, and 45 minutes after "fat" or placebo injection. The 99mTc DTPA clearance was measured throughout the duration of the study.
After calibration for contribution of tissue radioactivity to the lung detector the animals were killed with intravenous barbiturate and lungs either fixed in formalin and stained for fat or studied for extravascular lung water content.
Results

PERMEABILITY INDEX
During the baseline period before the injection of "fat" or placebo there was no significant difference in the clearance rate, expressed as Ti LB, in the three groups of animals (table). This clearance curve was almost invariably monoexponential except after embolisation with oleic acid when it could always be resolved into two clearly defined exponential curves. After the injection of oleic acid in the group 1 animals there was always a rapid increase in the clearance of 99mTc DTPA. In neither group 2 (triolein) or group 3 (placebo) was there any significant change in slope of the clearance curve. Three typical studies are shown in fig 1. The dramatic change in slope of the curve in animals given oleic acid could be resolved into an initial very rapid component, mean Ti 3-2 ± 0-6 min (SEM), and a slower second component, mean Ti 39 5 ± 7-6 min (SEM). Extrapolation of these curves to the time of injection showed that the fast component corresponded to a compartment containing 24-4 + 3 8 % of the radioactivity in the lung.
A-aPO2 DIFFERENCE Data for the three groups of animals are shown (fig 5a) . The oleic acid group showed much less staining for fat and the appearance of the staining was "smudgy" and less well defined than that seen in the triolein animals (fig 5b) . The placebo group showed no evidence of fat staining. 
Discussion
Using a modification of a simple test5 of the permeability of the alveolar epithelial membrane, we have shown quite characteristic types of effects on the lungs in our two groups of "fat" embolism animals. After intravenous injection of oleic acid the abrupt increase in permeability was in complete contrast to the absence of effect after intravenous triolein or placebo. The pattern of lung damage after oleic acid, measured from the 99mTc DTPA clearance curve, suggested that about 24% of the lung containing radioactive tracer was very severely damaged, the Ti LB falling from a control of 280 min to 3-2 min while the remainder of the lung was much less severely damaged. It is probable that the alveoli with the very short T1 LB were the major site of leakage of plasma through the alveolar capillary interface. This alveolar flooding produced a significant functional impairment, measured from gas exchange and compliance data, extensive radiological changes and an increase in postmortem bloodless lung water. The large difference in the permeability index between the oleic acid group on the one hand and the triolein and placebo groups A dose of 0d15 ml of fat/kg of body weight is equivalent to gross fat embolism in the lungs of man.10 The dose used in our rabbits (0-1 ml/kg oleic acid, 0 3 ml/kg triolein) may thus be a reasonable approximation to the amount of fat in the lungs of patients with severe fat embolism. The intravenous doses of oleic acid and triolein were one-third of the LD5o dose in rabbits for these fats. 4 
